Market access in Spain
Pharmaceutical Marketing Europe May/June 2007
To read the article on the changes to market access in Spain, written by Francois Lucas, click here.

Risk minimisation and communications
Pharmaceutical Marketing Europe July/August 2007
To read the article on risk minimisation and communications written by Dr Swapu Banerjee and Dr Beverly Barr, click here.

Risk Management Survey Results
In early 2006, Pope Woodhead conducted a survey to understand how the industry is responding to the EMEA’s EU-RMP legislation. The results were presented as a poster at the annual ISOP meeting in Liege, Belgium (11–13 October 2006). View poster

In a letter to Drug Safety the need for open communication of benefit/risk issues between pharmaceutical companies and their stakeholders (regulators, health authorities, doctors and patients) and how the industry is tackling this was discussed.
View Letter